Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.198NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.1.198NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.198NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.366EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.366NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.366NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.1.366NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.366NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.441EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.441NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.441NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.441NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.441NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.416EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.416NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.416NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.416NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.416NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.63EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.63NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.63NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.1.63NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.63NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.263EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.263NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.263NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.1.263NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.263NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.135EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.135NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.1.135NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.1.135NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.135NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
FK.1.4.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FK.1.4.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FK.1.4.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
FK.1.4.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FK.1.4.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.13EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.13NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
B.1.13NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
B.1.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.13NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
DR.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
DR.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
DR.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
DR.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
DR.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.160.15EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.160.15NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used